Log in to search using one of your social media accounts:

 

Propeller Health releases asthma forecasting API for open use

Madison, Wisconsin-based Propeller Health is taking its asthma alert messaging to the masses, as the longtime digital respiratory health company announced today that it is releasing Air, a free and open API that provides information on local asthma conditions.
Source: mobihealthnews - Category: Information Technology Source Type: news

Related Links:

Conclusions: Even when the rheumatological assessment scored EGPA “under control” according to the Birmingham Vasculitis Activity Score and Vasculitis Damage Index, sinonasal diseases and related nasal inflammatory processes were not controlled. Therefore, there is a need for clinical monitoring and targeted treatment to control the inflammatory processes and improve the QoL of EGPA patients.Int Arch Allergy Immunol
Source: International Archives of Allergy and Immunology - Category: Allergy & Immunology Source Type: research
The New York Public Library launched ‘Library Shelfie Day’, a social media event, a few years ago as a way to promote libraries and demonstrate a love of reading. The idea worked well with Instagram and was an international hit with over 1200 posts. Why did people like it so much? A number of factors contributed to this phenomenon. It definitely resonated with what people cared about, their passion for reading. Wonderful books include both the courageous and inspiring stories of individuals as well as reveal the health barriers members of our society must face. The PNR staff loves to read and here are a few of...
Source: Dragonfly - Category: Databases & Libraries Authors: Tags: Health Literacy/Consumer Health Public Libraries reading social media Source Type: news
Conclusion: In extremely preterm infants, early vitamin D supplementation did not significantly improve cognitive scores. Though underpowered for clinically meaningful differences in early childhood outcomes, this trial may help determine dosing for further investigation of vitamin D supplementation.Neonatology 2018;113:256-262
Source: Neonatology - Category: Perinatology & Neonatology Source Type: research
Areport released this morning by the National Academy of Sciences confirms that despite the demonization of vaping by many anti-tobacco groups and health departments, use of these products is much safer than smoking, and there are no known long-term health effects associated with vaping.This does not mean, of course, that vaping is safe. It just means that we don't know what the long-term effects may be. But it is important to stress that at this time, we don't know of any long-term adverse health effects.The report also concludes that the " second-hand " aerosol produced by vaping is safer than secondhand tobacc...
Source: The Rest of the Story: Tobacco News Analysis and Commentary - Category: Addiction Source Type: blogs
A severe shortage of GPs and rising patient demand is making it 'increasingly difficult' for practices to maintain asthma care, the RCGP has warned.
Source: GP Online News - Category: Primary Care Tags: 15.8 Respiratory Problems Source Type: news
The UK Medicines and Healthcare Products Regulatory Agency has given Pulmatrix (NSDQ:PULM) the go-ahead to launch its first-in-human study for an inhaled formulation of the anti-fungal drug, itraconazole. The company is evaluating its drug, Pulmazole, as a treatment for allergic bronchopulmonary aspergillosis in patients with asthma. Get the full story at our sister site, Drug Delivery Business News. The post Pulmatrix wins EU nod for inhaled dry-powder anti-fungal trial appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Clinical Trials Pharmaceuticals Regulatory/Compliance Respiratory Wall Street Beat Pulmatrix Inc. Source Type: news
Majority of patients do not get the basic care which could prevent two out of three asthma deaths
Source: BBC News | Health | UK Edition - Category: Consumer Health News Source Type: news
There are a huge number of misconceptions about the lung condition even though it affects 5.4 million people across the UK.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Immunotherapy, Ahead of Print.
Source: Immunotherapy - Category: Allergy & Immunology Authors: Source Type: research
Source: Pediatric Pulmonology - Category: Respiratory Medicine Authors: Tags: LETTERS TO THE EDITOR Source Type: research
More News: Asthma | Information Technology | Respiratory Medicine